跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bone Morphogenetic Protein 6
首页
药物
Bone Morphogenetic Protein 6
Bone Morphogenetic Protein 6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTAGONISTS
US 2022073598 A1
申请人: KYMAB LTD
优先权: 2018
CN
EP
US
WO
5 件公开
HUMAN ANTIBODIES TO BONE MORPHOGENETIC PROTEIN 6
EP 3983436 A1
申请人: REGENERON PHARMA
优先权: 2019
EP
US
WO
4 件公开
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)
US 11434269 B2
申请人: NOVARTIS AG
优先权: 2016
CN
US
2 件公开
Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
US 7910552 B2
申请人: BBS BIOACTIVE BONE SUBSTITUTES OY
优先权: 2005
US
2 件公开
BMP Mutants with Decreased Susceptibility to Noggin
US 2011039773 A1
申请人: STRYKER BIOTECH
优先权: 2008
US
2 件公开
Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
US 2003225021 A1
申请人: MCKAY WILLIAM F
优先权: 2003
US
Bone Morphogenetic Protein (BMP) binding domains of proteins of the Repulsive Guidance Molecule (RGM) protein family and functional fragments thereof and their application
EP 2033971 A1
申请人: ABBOTT GMBH & CO KG
优先权: 2007
EP
Methods, regimens, combinations and antagonists
CN 116059345 A
申请人: KYMAB LTD
优先权: 2016
CN
Vascular calcification prevention and treatment
US 11344575 B2
申请人: SUMMIT INNOVATION LABS LLC
优先权: 2017
US
Treatment and Prevention of Bone and Joint Disorders
US 2019015448 A1
申请人: TZEGHAI GHEBRE EGZIABHER
优先权: 2018
US
第 1 / 2 页
上一页
下一页
药物
反馈